ABVC Biopharma Correlations
| ABVC Stock | USD 0.80 0.01 1.48% |
The current 90-days correlation between ABVC Biopharma and Indaptus Therapeutics is -0.12 (i.e., Good diversification). The correlation of ABVC Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
ABVC Biopharma Correlation With Market
Good diversification
The correlation between ABVC Biopharma and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and DJI in the same portfolio, assuming nothing else is changed.
ABVC |
Moving against ABVC Stock
| 0.31 | A | Agilent Technologies | PairCorr |
| 0.58 | CPRX | Catalyst Pharmaceuticals Buyout Trend | PairCorr |
| 0.4 | CNTA | Centessa Pharmaceuticals Downward Rally | PairCorr |
| 0.35 | ADUS | Addus HomeCare | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ABVC Stock performing well and ABVC Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ABVC Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| INDP | 3.24 | (0.28) | 0.00 | 0.97 | 0.00 | 6.32 | 20.25 | |||
| KTTA | 4.50 | (1.11) | 0.00 | (1.02) | 0.00 | 8.06 | 53.63 | |||
| BTTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| FBRX | 8.10 | 1.67 | 0.23 | 0.34 | 6.44 | 14.10 | 146.60 | |||
| EVLO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| APTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MGTA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ALRN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ARDS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| AKTX | 5.42 | (0.54) | 0.00 | (1.72) | 0.00 | 11.21 | 41.26 |
ABVC Biopharma Corporate Management
| TsungShann Jiang | Member Officer | Profile | |
| Leeds Chow | Chief Officer | Profile | |
| Howard MD | Pres CEO | Profile | |
| ChiHsin King | Chief Officer | Profile | |
| Uttam Patil | Chief Officer | Profile | |
| Eugene Jiang | Chairman Officer | Profile |